Price source: Yahoo · live price · as of 23:00 · 289 trading days · fundamentals: yfinance
Stock summary — overview
Free for allTechnically, Johnson & Johnson is in a clear uptrend (above most moving averages), and momentum is positive. The weighted indicators point to “Strong Buy”. Analysts are pricing in avg target $253 (+5%), buy. High institutional ownership (77%) signals smart-money confidence. Market backdrop: Positive market (Risk-On) — S&P 500 above the 200-day SMA, 1-month return -0.1%; VIX 16.7 (normal). Recent news sentiment: Positive sentiment (4 positive / 0 negative). Bottom line: most factors align positively — a setup that supports an entry, subject to risk management.
Day
+1.07%
Week
+3.48%
Month
+4.54%
Year
+55.14%
המידע באתר מבוסס על ניתוח טכני ואלגוריתם AI ואינו מהווה ייעוץ השקעות או תחליף לייעוץ מקצועי. המסחר בשוק ההון כרוך בסיכון והאחריות על השימוש בנתונים היא על המשתמש בלבד.
Technical balance: Strong Buy (score +65.4)
✅ Technical signal: Strong Buy (9↑/2↓)
✅ Analysts: avg target $253 (+5%), buy
✅ Market: Positive market (Risk-On)
✅ News: Positive sentiment
✅ Institutional backing: 77% institutional
Price vs SMA100
+2.63%
🟢 BuyAbove SMA 100
Price vs SMA150
+7.12%
🟢 BuyAbove SMA 150
Price vs SMA200
+12.24%
🟢 BuyAbove SMA 200
50/200 Cross
Golden
🟢 BuyLong-term uptrend
Bollinger %B
99
🔴 SellAt the upper band — stretched
Stochastic %K
96.5
🔴 SellOverbought
RVOL
0.82
⚪ NeutralNormal volume
52-week position
89.44%
🟢 BuyNear the high — relative strength
ATR %
1.83%
⚪ NeutralLow volatility
Sign up free for full access to indicators, support/resistance levels and analyst targets.
Sign up free — completely freeRecent rating changes
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| May 13, 2026 | Leerink Partners | up | Outperform ← Market Perform | $265.00 |
| Apr 15, 2026 | Barclays | main | Equal-Weight ← Equal-Weight | $255.00 |
| Apr 15, 2026 | Stifel | main | Hold ← Hold | $250.00 |
| Apr 15, 2026 | Wells Fargo | main | Overweight ← Overweight | $263.00 |
| Apr 10, 2026 | Morgan Stanley | main | Overweight ← Overweight | $267.00 |
| Mar 30, 2026 | RBC Capital | reit | Outperform ← Outperform | $255.00 |
| Mar 19, 2026 | Barclays | main | Equal-Weight ← Equal-Weight | $234.00 |
| Mar 17, 2026 | HSBC | main | Buy ← Buy | $280.00 |
Source: Yahoo Finance · consensus and targets update continuously. For thinly-covered stocks the latest rating change may be from a while ago — it's the most recent reported event, not stale data.
Sign up free for full access to indicators, support/resistance levels and analyst targets.
Sign up free — completely freeNext earnings
2026-07-15
Est. EPS
2.85
Est. revenue
$25.01B
Dividend
2026-06-09
Management & founders